Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma-Reference-Cited by-同舟云学术

Assessment of Erythroid and Granulocytic Hematopoietic Lineages in Patients with Non-Small-Cell Lung Carcinoma

Published:2017-08 Issue:4 Volume:163 Page:469-474
ISSN:0007-4888
Container-title:Bulletin of Experimental Biology and Medicine
language:en
Short-container-title:Bull Exp Biol Med

Author:

Goldberg V. E.,Polyakova T. Yu.,Popova N. O.,Vysotskaya V. V.,Simolina E. I.,Belevich Yu. V.,Tuzikova T. P.,Goldberg A. V.,Zhdanov V. V.,Miroshnichenko L. A.,Udut E. V.,Simanina E. V.,Dygai A. M.,Zyuz’kov G. N.

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/article/10.1007/s10517-017-3830-y/fulltext.html

Reference15 articles.

1. Bagrova SG, Bychkov MB, Gorbunova VA, Kuzminov AE, Naskhletashvili DR. Comparative evaluation of different regimen of platinum-based chemotherapy in treatment of advanced small cell lung cancer (experience of chemotherapy department N. N. Blokhin Russian Cancer Research Center RAMS). Ross. Onkol. Zh. 2013(2):4-10. Russian.

2. Goldberg ED, Dygai AM, Zhdanov VV, Zyuz’kov GN, Gyr’yantseva LA, Pershina OV, Simanina EV, Skurikhin EG, Stavrova LA, Udut EV, Minakova MYu, Khrichkova TYu, Firsova TV.The theory of hematopoiesis regulation and creation of new drugs for the therapy of blood system pathology on its basis. Bull. Exp. Biol. Med. 2008;(Suppl. 2):6-13. Russian.

3. Zhdanov VV, Gol’dberg VE, Khrichkova TYu, Matyash MG, Gur’yantseva LA, Simolina EI, Vysotskaya VV, Suslov NI, Popova NO, Dygai AM. The hemostimulant effect of cropanol under the conditions of myelosuppression induced by cytostatic agents. Eskp. Klin. Farmakol. 2002;65(6):37-40. Russian.

4. Koroleva IA, Kopp MV, Shaplygin LV. Prophylaxis and treatment of chemotherapy-induced neutropenia and anemia. Klin. Onkogenatol. 2012;5(3):246-254. Russian.

5. Pokrovskaya OS. Mechanism of action and clinical activity of CXCR4 antagonist Plerixafor in stem cell mobilization. Klin. Onkogenatol. 2012;5(4):371-379. Russian.